Document is current
Any future updates will be listed below
-
Authors
Guadalajara, H. https://orcid.org/0000-0001-6297-9347
García-Arranz, M.
Herreros, M. Dolores
Borycka-Kiciak, K. https://orcid.org/0000-0001-6022-2906
Lightner, A. L.
García-Olmo, D.
- License Information
-
More Information
Article History
Received: 16 April 2020
Accepted: 19 May 2020
First Online: 1 June 2020
Compliance with ethical standards
:
: García-Olmo D is a member of the Advisory Board of Tigenix S. A. U. and has received fees from Takeda. García-Olmo D and Garcia-Arranz M have applied for two patents related to this study entitled “Identification and isolation of multipotent cells from nonosteochondral mesenchymal tissue” (WO 2006/057649) and “Use of adipose tissue-derived stromal stem cells in treating fistula” (WO 2006/136244). García-Olmo D, Guadalajara H, and Garcia-Arranz M are shareholders of Biosurgery, an educational company that provides services to Takeda Pharmaceutical. Amy L. is a consultant for Takeda Pharmaceutical.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.
